Attached files
file | filename |
---|---|
EX-99.2 - EX-99.2 - Foundation Healthcare, Inc. | d70402exv99w2.htm |
8-K/A - AMENDMENT TO FORM 8-K - Foundation Healthcare, Inc. | d70402e8vkza.htm |
EX-99.5 - EX-99.5 - Foundation Healthcare, Inc. | d70402exv99w5.htm |
EX-99.4 - EX-99.4 - Foundation Healthcare, Inc. | d70402exv99w4.htm |
Exhibit 99.3
Report of Independent Registered Public Accounting Firm
To the Audit Committee, Board of Directors,
and Shareholders of Graymark Healthcare, Inc.
and Shareholders of Graymark Healthcare, Inc.
We have audited the accompanying balance sheets of somniTech, Inc. as of June 30, 2009 and 2008,
and the related statements of operations, shareholders equity, and cash flows for the years then
ended. These financial statements are the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatements.
The Company is not required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included consideration of internal control over
financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the
Companys internal control over financial reporting. Accordingly, we express no such opinion. An
audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statement presentation. We believe that
our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the financial position of the Company as of June 30, 2009 and 2008, and the results of
its operations and its cash flows for the years then ended, in conformity with accounting
principles generally accepted in the United States of America.
/s/ Eide Bailly LLP
December 17, 2009
Minneapolis, Minnesota
Minneapolis, Minnesota
F-1
SOMNITECH, INC.
Balance Sheets
As of June 30, 2009 and 2008
As of June 30, 2009 and 2008
2009 | 2008 | |||||||
ASSETS |
||||||||
Cash and cash equivalents |
$ | 89,985 | $ | 242,714 | ||||
Accounts receivable, net of allowance for doubtful
accounts of $80,201 and $97,634, respectively |
815,487 | 939,704 | ||||||
Receivable from somniCare, Inc. |
| 143,184 | ||||||
Other current assets |
18,914 | 24,529 | ||||||
Total current assets |
924,386 | 1,350,131 | ||||||
Property and equipment, net |
840,522 | 1,051,411 | ||||||
Intangible assets, net |
103,316 | 123,979 | ||||||
Goodwill |
3,055,189 | 2,322,612 | ||||||
Other assets |
389,799 | 23,518 | ||||||
Total assets |
$ | 5,313,212 | $ | 4,871,651 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Liabilities: |
||||||||
Accounts payable |
$ | 118,773 | $ | 125,588 | ||||
Accrued liabilities |
1,014,410 | 966,871 | ||||||
Payable to somniCare, Inc. |
281,102 | | ||||||
Short-term debt |
919,423 | 500,000 | ||||||
Current portion of long-term debt |
283,305 | 271,357 | ||||||
Total current liabilities |
2,617,013 | 1,863,816 | ||||||
Deferred tax liabilities |
54,436 | 44,802 | ||||||
Long-term debt, net of current portion |
403,117 | 320,607 | ||||||
Total liabilities |
3,074,566 | 2,229,225 | ||||||
Shareholders Equity: |
||||||||
Common stock $0.0001 par value, 1,000 shares
authorized, issued and outstanding |
| | ||||||
Paid-in capital |
1,175,577 | 1,636,746 | ||||||
Retained earnings |
1,063,069 | 1,005,680 | ||||||
Total shareholders equity |
2,238,646 | 2,642,426 | ||||||
Total liabilities and shareholders equity |
$ | 5,313,212 | $ | 4,871,651 | ||||
See Accompanying Notes to Financial Statements
F-2
SOMNITECH, INC.
Statements of Operations
For the Years Ended June 30, 2009 and 2008
For the Years Ended June 30, 2009 and 2008
2009 | 2008 | |||||||
Revenues |
$ | 7,886,742 | $ | 7,885,556 | ||||
Cost of sales |
2,745,763 | 2,521,925 | ||||||
Gross profit |
5,140,979 | 5,363,631 | ||||||
Costs and Expenses: |
||||||||
Selling, general and administrative |
4,586,989 | 4,636,629 | ||||||
Depreciation and amortization |
389,203 | 417,600 | ||||||
4,976,192 | 5,054,229 | |||||||
Income from continuing operations |
164,787 | 309,402 | ||||||
Other (Income) Expense: |
||||||||
Interest expense |
94,296 | 83,703 | ||||||
Other (income) |
(18,999 | ) | (10,704 | ) | ||||
Total other expense, net |
75,297 | 72,999 | ||||||
Net income before provision for income taxes |
89,490 | 236,403 | ||||||
Provision for income taxes |
32,101 | 85,376 | ||||||
Net income |
$ | 57,389 | $ | 151,027 | ||||
See Accompanying Notes to Financial Statements
F-3
SOMNITECH, INC.
Statements of Shareholders Equity
For the Years Ended June 30, 2009 and 2008
For the Years Ended June 30, 2009 and 2008
Additional | ||||||||||||||||
Common Stock | Paid-In | Retained | ||||||||||||||
Shares | Amount | Capital | Earnings | |||||||||||||
Balance, June 30, 2007 |
1,000 | $ | | $ | 2,029,938 | $ | 854,653 | |||||||||
Distributions to Parent |
| | (393,192 | ) | | |||||||||||
Net income |
| | | 151,027 | ||||||||||||
Balance, June 30, 2008 |
1,000 | | 1,636,746 | 1,005,680 | ||||||||||||
Contributions from Parent |
| | 350,408 | | ||||||||||||
Distributions to Parent |
| | (811,577 | ) | | |||||||||||
Net income |
| | | 57,389 | ||||||||||||
Balance, June 30, 2009 |
1,000 | $ | | $ | 1,175,577 | $ | 1,063,069 | |||||||||
See Accompanying Notes to Financial Statements
F-4
SOMNITECH, INC.
Statements of Cash Flows
For the Years Ended June 30, 2009 and 2008
For the Years Ended June 30, 2009 and 2008
2009 | 2008 | |||||||
Operating activities: |
||||||||
Net income |
$ | 57,389 | $ | 151,027 | ||||
Adjustments to reconcile net income to net cash
provided by operating activities: |
||||||||
Depreciation and amortization |
389,203 | 417,600 | ||||||
Deferred income taxes |
9,634 | 3,317 | ||||||
Changes in assets and liabilities |
||||||||
Accounts receivable |
124,217 | (115,246 | ) | |||||
Due to / from somniCare, Inc. |
424,286 | 199,052 | ||||||
Other assets |
5,615 | 21,017 | ||||||
Accounts payable |
(6,815 | ) | 4,641 | |||||
Other liabilities |
22,385 | 91,481 | ||||||
Net cash provided by operating activities |
1,025,914 | 772,889 | ||||||
Investing activities: |
||||||||
Payment of earnout obligation |
(288,000 | ) | | |||||
Purchase of property and equipment |
(157,651 | ) | (185,864 | ) | ||||
Deposit paid on software and equipment |
(366,281 | ) | | |||||
Net cash used in investing activities |
(811,932 | ) | (185,864 | ) | ||||
Financing activities: |
||||||||
Contributions from Parent |
350,408 | | ||||||
Distributions to Parent |
(811,577 | ) | (393,192 | ) | ||||
Debt proceeds |
376,393 | 143,043 | ||||||
Debt payments |
(281,935 | ) | (471,203 | ) | ||||
Net cash used in financing activities |
(366,711 | ) | (721,352 | ) | ||||
Net change in cash and cash equivalents |
(152,729 | ) | (134,327 | ) | ||||
Cash and cash equivalents at beginning of year |
242,714 | 377,041 | ||||||
Cash and cash equivalents at end of year |
$ | 89,985 | $ | 242,714 | ||||
Noncash Investing and Financing Activities: |
||||||||
Seller-financing of earnout obligation |
$ | 419,423 | $ | | ||||
Accrual of earnout obligation |
$ | 25,154 | $ | 707,423 | ||||
Cash Paid for Interest and Income Taxes: |
||||||||
Interest expense |
$ | 94,000 | $ | 84,000 | ||||
Income taxes |
$ | | $ | | ||||
See Accompanying Notes to Financial Statements
F-5
SOMNITECH, INC.
Notes to Financial Statements
For the Years Ended June 30, 2009 and 2008
Note 1 Nature of Business
somniTech, Inc. (the Company) is organized in Kansas and is a wholly-owned
subsidiary of Avastra, LTD., an Australian corporation (the Parent). The Company
provides sleep testing services and treatment for sleep disorders at sleep diagnostic
centers in Iowa, Kansas, Minnesota, Missouri, Nebraska and South Dakota. The Companys
services are used primarily by patients with obstructive sleep apnea. These centers
provide monitored sleep diagnostic testing services to determine sleep disorders in the
patients being tested. The majority of the sleep testing is to determine if a patient has
obstructive sleep apnea. Positive airway pressure provided by sleep/personal ventilation
(or CPAP) equipment is the American Academy of Sleep Medicines preferred method of
treatment for obstructive sleep apnea. The Companys sleep diagnostic facilities also
determine the correct pressure settings for patient treatment with positive airway
pressure.
Note 2 Summary of Significant Accounting Policies
Use of estimates The preparation of financial statements in conformity with
generally accepted accounting principles requires management of the Company to make
estimates and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.
Subsequent events We have evaluated subsequent events through the date the
financial statements were issued on December 17, 2009.
Revenue recognition Revenue from sleep center services are recognized in the period
in which services are provided to customers and are recorded at net amounts estimated to be
paid by the third party payors or customers. Insurance benefits are assigned to the
Company and the Company bills on behalf of its customers.
Cash and cash equivalents The Company considers all highly liquid temporary cash
investments with an original maturity of three months or less to be cash equivalents.
Accounts receivable Accounts receivable are reported net of allowances for doubtful
accounts of $80,201 and $97,634 as of June 30, 2009 and 2008, respectively. The majority
of the Companys accounts receivable are due from private insurance carriers, Medicaid /
Medicare and other third party payors, as well as from customers under co-insurance and
deductible provisions.
The Companys allowance for doubtful accounts is an estimate of net amounts
collectable based on the age of the accounts and historic collection patterns from the
various payors. Accounts are written-off when, due to the age of the account or based on
other specific information, the account is deemed uncollectable.
Property and equipment Property and equipment is stated at cost and depreciated
using the straight line method to depreciate the cost of various classes of assets over
their estimated useful lives. At the time assets are sold or otherwise disposed of, the
cost and accumulated depreciation are eliminated from the asset and depreciation accounts;
profits and losses on such dispositions are reflected in current operations. Fully
depreciated assets are written off against accumulated depreciation. Expenditures for
major renewals and betterments that extend the useful lives of
property and equipment are capitalized. Expenditures for maintenance and repairs are
charged to expense as incurred.
F-6
The estimated useful lives of the Companys property and equipment are as follows:
Asset Class | Useful Life | |
Equipment
|
5 to 7 years | |
Software
|
3 to 7 years | |
Furniture and fixtures
|
7 years | |
Leasehold improvements
|
25 years or remaining lease period, whichever is shorter | |
Vehicles
|
3 to 5 years |
Goodwill and Intangible Assets Goodwill is the excess of the purchase price paid
over the fair value of the net assets of the acquired business. Goodwill and other
indefinitely lived intangible assets are not amortized, but are subject to annual
impairment reviews, or more frequent reviews if events or circumstances indicate there may
be an impairment of goodwill.
Intangible assets other than goodwill which consist of covenants not to compete are
amortized over their estimated useful lives of seven years using the straight line method.
The Company evaluates the recoverability of identifiable intangible asset whenever events
or changes in circumstances indicate that an intangible assets carrying amount may not be
recoverable.
Advertising Costs Advertising and sales promotion costs are expensed as incurred.
Advertising expense for the years ended June 30, 2009 and 2008 totaled $62,554 and $54,261,
respectively.
Income Taxes The Company is part of a controlled group owned by Parent that
collectively file a consolidated income tax return. Income taxes payable are recorded as a
liability until such time as settled with Parent.
The Company recognizes deferred tax assets and liabilities for future tax consequences
attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases and tax credit carry-forwards.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply
to taxable income in the years in which those temporary differences are expected to be
recovered or settled. The effect of deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes the enactment date. In the event
the Company determines that the deferred tax assets will not be realized in the future, the
valuation adjustment to the deferred tax assets is charged to earnings in the period in
which the Company makes such a determination.
The Company uses a two-step process to evaluate a tax position. The first step is to
determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigation based on the
technical merits of that position. The second step is to measure a tax position that meets
the more-likely-than-not threshold to determine the amount of benefit to be recognized in
the financial statements. A tax position is measured at the largest amount of benefit that
is greater than 50 percent likely of being realized upon ultimate settlement.
Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is
met. Previously recognized tax positions that no longer meet the more-likely-than-not
criteria should be de-recognized in the first subsequent financial reporting period in
which the threshold is no longer met. The Company reports tax-related interest and
penalties as a component of income tax expense.
Based on all known facts and circumstances and current tax law, the Company believes
that the total amount of unrecognized tax benefits as of June 30, 2009, is not material to
its results of
operations, financial condition or cash flows. The Company also believes that the
total amount of unrecognized tax benefits as of June, 2009, if recognized, would not have a
material effect on its effective tax rate. The Company further believes that there are no
tax positions for which it is reasonably possible, based on current tax law and policy that
the unrecognized tax benefits will significantly increase or decrease over the next 12
months producing, individually or
F-7
in the aggregate, a material effect on the Companys results of operations, financial condition or
cash flows.
Fair value of financial instruments The recorded amounts of cash and cash
equivalents, other receivables, and accrued liabilities approximate fair value because of
the short-term maturity of these items. The Company calculates the fair value of its
borrowings based on estimated market rates. Fair value estimates are based on relevant
market information and information about the individual borrowings. These estimates are
subjective in nature, involve matters of judgement and therefore, cannot be determined with
precision. Estimated fair values are significantly affected by the assumptions used.
Based on the Companys calculations at June 30, 2009 and 2008, the carrying amount of the
Companys borrowings approximates fair value.
New Accounting Pronouncements
FIN 48 In June 2006, the Financial Accounting Standards Board (FASB) issued
Interpretation 48,
Accounting for Uncertainty in Income Taxes an Interpretation of FASB Statement No. 109 (FIN
48). FIN 48 is intended to clarify the accounting for uncertainty in income taxes recognized in a
companys financial statements and prescribes the recognition and measurement of a tax position
taken or expected to be taken in a tax return. FIN 48 also provides guidance on de-recognition,
classification, interest and penalties, accounting in interim periods, disclosure and transition.
FIN 48 became effective for the years beginning after December 15, 2006.
Under FIN 48, evaluation of a tax position is a two-step process. The first step is
to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigation based on the
technical merits of that position. The second step is to measure a tax position that meets
the more-likely-than-not threshold to determine the amount of benefit to be recognized in
the financial statements. A tax position is measured at the largest amount of benefit that
is greater than 50 percent likely of being realized upon ultimate settlement.
Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is
met. Previously recognized tax positions that no longer meet the more-likely-than-not
criteria should be de-recognized in the first subsequent financial reporting period in
which the threshold is no longer met.
The adoption of FIN 48 did not have a material impact on the Companys financial
position, results of operations, or cash flows as of June 30, 2009 and 2008.
SFAS 157 In September 2006, the FASB issued Statement No. 157, Fair Value
Measurements (SFAS No. 157). SFAS 157 addresses how companies should measure fair value
when they are required to use a fair value measure for recognition or disclosure purposes
under GAAP. SFAS 157 defines fair value, establishes a framework for measuring fair value
and expands disclosures about fair value measurements. In February 2008, the FASB issued
FASB Staff Position No. 157-2, Effective Date of FASB Statement No. 157 which delays the
effective date of SFAS 157 for all nonfinancial assets and nonfinancial liabilities, except
those that are recognized or disclosed at fair value in the financial statements on a
recurring basis (at least annually) until January 1, 2009. The adoption of SFAS 157 did
not have a material impact on the Companys financial position, results of operations, or
cash flows.
SFAS 141(R) and SFAS 160 In December 2007, the FASB issued SFAS No. 141 (Revised),
Business Combinations (SFAS 141 (R)), replacing SFAS No. 141, Business Combinations
(SFAS 141), and SFAS 160, Noncontrolling Interests in Consolidated Financial
Statements an Amendment of ARB No. 51 (SFAS 160). SFAS 141(R) retains the
fundamental requirements of SFAS 141, and broadens its scope by applying the acquisition
method to all transactions and other events in which one entity obtains control over one or
more other businesses, and requires, among other things, that assets acquired and
liabilities assumed be measured at fair value as of the acquisition date, that liabilities
related to contingent consideration be recognized at the acquisition date and remeasured at
fair value in each subsequent reporting period, that acquisition-related costs be expensed
as incurred, and that income be recognized if the fair value of the net assets acquired
exceeds the fair value of the consideration transferred. SFAS 160 establishes accounting
and reporting standards for noncontrolling interests (i.e., minority
F-8
interests) in a subsidiary, including changes in a parents ownership interest in a subsidiary and
requires, among other things, that noncontrolling interests in subsidiaries be classified as a
separate component of equity. Except for the presentation and disclosure requirements of SFAS 160,
which are to be applied retrospectively for all periods presented, SFAS 141 (R) and SFAS 160 are to
be applied prospectively in financial statements issued for fiscal years beginning after December
15, 2008. Management is assessing the impact SFAS 160 will have on the Companys financial
statements.
Note 3 Property and Equipment
Following are the components of property and equipment included in the accompanying
balance sheets as of June 30, 2009 and 2008:
2009 | 2008 | |||||||
Equipment |
$ | 1,748,427 | $ | 1,665,976 | ||||
Furniture and fixtures |
543,561 | 537,499 | ||||||
Software |
262,952 | 256,001 | ||||||
Vehicles |
135,623 | 97,397 | ||||||
Leasehold improvements |
469,723 | 472,858 | ||||||
3,160,286 | 3,029,731 | |||||||
Accumulated depreciation |
(2,319,764 | ) | (1,978,320 | ) | ||||
$ | 840,522 | $ | 1,051,411 | |||||
Depreciation expense for the years ended June 30, 2009 and 2008 was $368,540 and
$396,937, respectively.
Note 4 Goodwill and Other Intangibles
The change in the carrying amount of goodwill during the year ended June 30, 2009 and
2008 was as follows:
June 30, 2007 |
$ | 1,615,189 | ||
Earnout obligation |
707,423 | |||
June 30, 2008 |
2,322,612 | |||
Earnout obligation |
732,577 | |||
June 30, 2009 |
$ | 3,055,189 | ||
The earnout obligation is to the former owner of the Company who is also a member of
the Companys management team.
As of June 30, 2009, the Company had $3.1 million of goodwill resulting from business
acquisitions. Goodwill and intangibles assets with indefinite lives must be tested for
impairment at least once a year. Carrying values are compared with fair values, and when
the carrying value exceeds the fair value, the carrying value of the impaired asset is
reduced to its fair value. The
Company tests goodwill for impairment on an annual basis in June or more frequently if
management believes indicators of impairment exist. The performance of the test involves a
two-step process. The first step of the impairment test involves comparing the fair values
of the applicable reporting units with their aggregate carrying values, including goodwill.
The Company generally determines the fair value of its reporting units using the income
approach methodology of valuation that includes the discounted cash flow method as well as
other generally accepted valuation methodologies. If the carrying amount of a reporting
unit exceeds the reporting units fair value, the Company performs the second step of the
goodwill impairment test to determine the amount of impairment loss. The second step of
the goodwill impairment test involves comparing the implied fair value of the affected
reporting units goodwill with the carrying value of that
goodwill.
F-9
The Companys evaluation of goodwill completed during June 2009 and 2008 resulted in
no impairment losses.
Intangible assets as of June 30, 2009 and 2008 include the following:
Useful | 2009 | 2008 | ||||||||||||||||||||||||||
Life | Gross | Accumulated | Gross | Accumulated | ||||||||||||||||||||||||
(Years) | Amount | Amortization | Net | Amount | Amortization | Net | ||||||||||||||||||||||
Covenants not to compete |
7 | $ | 144,642 | $ | (41,326 | ) | $ | 103,316 | $ | 144,642 | $ | (20,663 | ) | $ | 123,979 | |||||||||||||
Amortization expense for the years ended June 30, 2009 and 2008 was $20,663 and
$20,633, respectively. Amortization expense for the next five years related to theses
intangible assets is expected to be $20,633 in each year.
Note 5 Other Assets
As of June 30, 2009, the Company had on deposit $366,281 for the purchase of sleep
diagnostic software and equipment. The deposit is included in other assets in the
accompanying balance sheet. The Company is obligated to pay an additional $278,500 to
complete the purchase.
Note 6 Short Term Debt
As of June 30, 2009, the Company had a note payable to the former owner of the Company
in the amount of $419,423. The note bears interest at 8% per annum and matures on August
15, 2009. Interest on the note is payable monthly beginning on November 1, 2008; principal
is due at maturity. Interest expense paid to the former owner during the year ended June
30, 2009 was $30,445. No interest expense was paid to the former owner during the year
ended June 30, 2008. The Company granted a security interest in 100% of the Companys
common stock to the former owner of the Company to secure the Companys earnout obligations
and short-term debt owed to the former owner. This note was paid-off in August 2009.
As of June 30, 2009 and 2008, the Company had a line of credit to a bank in the amount
of $500,000. The line of credit is secured by a security interest in all assets of the
Company. The line of credit bears interest at 4.5% per annum and matures on October 31,
2009. Interest on the line of credit is due monthly. As of June 30, 2009, there was no
amount available to borrow on the line of credit.
Note 7 Long Term Debt
As of June 30, 2009 and 2008, the Company had notes payable to a bank totaling
$671,691 and $540,844, respectively. The notes are secured by a security interest in all
assets of the Company. The notes payable are secured by a security interest in all assets
of the Company. The notes bear interest at fixed rates ranging from 7.3% to 8.4% and
mature on dates ranging from July 29, 2009 to
June 1, 2013. As of June 30, 2009, the Company is required to make monthly payments
of principal and interest totaling $99,490. As of June 30, 2009, two of the notes payable
have a combined $336,790 which is still available to be drawn. The undrawn amount will be
advanced as the Company completes the purchase of the sleep diagnostic software and
equipment discussed in Note 5.
As of June 30, 2009 and 2008, the Company had notes payable used for the purchase of
vehicles and equipment totaling $14,731 and $51,121, respectively. The notes are secured
by the respective vehicle or equipment financed and bear interest at fixed rates ranging
from 4% to 13% and mature on dates ranging from October 1, 2009 to September 23, 2010. As
of June 30, 2009, the Company is required to make monthly payments of principal and
interest totaling $4,903.
F-10
At June 30, 2009, future maturities of long-term debt were as follows:
2010 |
$ | 283,305 | ||
2011 |
193,892 | |||
2012 |
109,085 | |||
2013 |
100,140 |
Note 8 Operating Leases
The Company leases all of the real property used in its business for office space and
sleep testing facilities under operating lease agreements. Rent is expensed as paid
consistent with the terms of each lease agreement over the term of each lease. In addition
to minimum lease payments, certain leases require reimbursement for common area maintenance
and insurance, which are expensed when incurred.
The Companys rental expense for operating leases the years ended June 30, 2009 and
2008 was $610,620 and $586,103, respectively.
Following is a summary of the future minimum lease payments under operating leases as of
June 30, 2009:
2010 |
$ | 531,474 | ||
2011 |
473,051 | |||
2012 |
293,901 | |||
2013 |
229,559 | |||
2014 |
194,519 | |||
Thereafter |
2,440,000 | |||
Total |
$ | 4,162,504 | ||
Note 9 Income Taxes
The Companys income tax provision for the years ended June 30, 2009 and 2008 consists of:
2009 | 2008 | |||||||
Current provision |
$ | 22,467 | $ | 82,059 | ||||
Deferred provision |
9,634 | 3,317 | ||||||
Total |
$ | 32,101 | $ | 85,376 | ||||
Deferred income tax assets and liabilities as of June 30, 2009 and 2008 are comprised of:
2009 | 2008 | |||||||
Deferred income tax assets: |
||||||||
Intangible assets |
$ | 10,102 | $ | 5,694 | ||||
Accounts receivable |
32,080 | 39,054 | ||||||
Total deferred tax assets |
42,182 | 44,748 | ||||||
Deferred income tax liabilities: |
||||||||
Fixed assets, net |
(96,618 | ) | (89,550 | ) | ||||
Deferred tax liability, net |
$ | (54,436 | ) | $ | (44,802 | ) | ||
The provision for income taxes differs from the amount computed by multiplying income
before taxes by the statutory federal income tax rate due to state income taxes,
differences between book and tax depreciation and amortization, and nondeductible allowance
for bad debts. Income taxes payable at June 30, 2009 and 2008, was $104,516 and $82,059,
respectively.
F-11
Note 10 Related Party Transaction
The Companys corporate offices are occupied under a 60-month lease with Tripod,
L.L.C. (Tripod), requiring monthly rental payments of $12,696; the lease matures on
September 30, 2011. Ms. Pamela R. Gillis, a member of the Companys management team,
controls Tripod. During the year ended June 30, 2009 and 2008, the Company incurred
$152,352 in lease expense under the terms of the lease.
One of the Companys sleep center location is occupied under a 25 year lease with PRG,
L.L.C. (PRG), requiring monthly rental payments of $15,250; the lease matures on October
31, 2027. Ms. Pamela R. Gillis, a member of the Companys management team, controls PRG.
During the year ended June 30, 2009 and 2008, the Company incurred $183,000 in lease
expense under the terms of the lease.
During the year ended June 30, 2009 and 2008, the Company paid Parent $205,400 and
$102,900, respectively, for billing and collection services performed by Parent on behalf
of the Company.
As of June 30, 2009, the Company had a payable to somniCare, Inc. (somniCare) for
$281,102. As of June 30, 2008, the Company had a receivable from somniCare for $143,184.
somniCare is an entity under common ownership of Parent.
Note 11 Subsequent Event
On August 24, 2009, 100% of the ownership of the Company was sold to Graymark
Healthcare, Inc. (Graymark) for $2,594,000. In conjunction with the sale to Graymark,
Graymark settled all existing and future earnout obligations with the former owner of the
Company.
F-12